RONDA E. STRYKER - 30 Jan 2025 Form 4 Insider Report for STRYKER CORP (SYK)

Signature
/s/ Austin Y. Ke, attorney-in-fact for Ronda E. Stryker
Issuer symbol
SYK
Transactions as of
30 Jan 2025
Net transactions value
-$78,639,906
Form type
4
Filing time
03 Feb 2025, 16:44:52 UTC
Previous filing
07 Nov 2024
Next filing
04 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYK Common Stock Options Exercise $353,163 +3,795 +96% $93.06 7,735 30 Jan 2025 Direct
transaction SYK Common Stock Sale $37,810,975 -96,728 -2.5% $390.90 3,746,739 31 Jan 2025 By Revocable Trust F1, F2
transaction SYK Common Stock Sale $15,206,116 -38,802 -1% $391.89 3,707,937 31 Jan 2025 By Revocable Trust F3
transaction SYK Common Stock Sale $2,930,253 -7,462 -0.2% $392.69 3,700,475 31 Jan 2025 By Revocable Trust F4
transaction SYK Common Stock Sale $7,084,583 -17,983 -0.49% $393.96 3,682,492 31 Jan 2025 By Revocable Trust F5
transaction SYK Common Stock Sale $14,846,341 -37,599 -1% $394.86 3,644,893 31 Jan 2025 By Revocable Trust F6
transaction SYK Common Stock Sale $1,114,801 -2,818 -0.08% $395.60 3,642,075 31 Jan 2025 By Revocable Trust F7
holding SYK Common Stock 14,294,056 30 Jan 2025 By L. Lee Stryker Trust
holding SYK Common Stock 37,600 30 Jan 2025 By 1988 William D. Johnston Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYK Stock Option granted 02/11/2015 (right to buy) Options Exercise $0 -3,795 -100% $0.000000 0 30 Jan 2025 Common Stock 3,795 $93.06 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $390.39 to $391.38, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F2 Includes 756,859 shares previously owned by the L. Lee Stryker Trust which were transferred to the Revocable Trust on November 15, 2024.
F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $391.385 to $392.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $392.38 to $393.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $393.38 to $394.375, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F6 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $394.38 to $395.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F7 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $395.39 to $395.85, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F8 Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.